Bimatoprost en es it fr

Bimatoprost Brand names, Bimatoprost Analogs

Bimatoprost Brand Names Mixture

  • No information avaliable

Bimatoprost Chemical_Formula


Bimatoprost RX_link

Bimatoprost fda sheet

Bimatoprost FDA

Bimatoprost msds (material safety sheet)

Bimatoprost MSDS

Bimatoprost Synthesis Reference

No information avaliable

Bimatoprost Molecular Weight

415.566 g/mol

Bimatoprost Melting Point

No information avaliable

Bimatoprost H2O Solubility

Slightly soluble

Bimatoprost State


Bimatoprost LogP


Bimatoprost Dosage Forms

Ophthalmic solution (0.03%)

Bimatoprost Indication

For the reduction of elevated intraocular pressure in patients with open angle glaucoma or ocular hypertension who are intolerant of other intraocular pressure lowering medications or insufficiently responsive (failed to achieve target IOP determined after multiple measurements over time) to another intraocular pressure lowering medication.

Bimatoprost Pharmacology

Bimatoprost is a prostamide, a synthetic structural analog of prostaglandin with ocular hypotensive activity. It selectively mimics the effects of naturally occurring substances, prostamides. Bimatoprost lowers intraocular pressure (IOP) in humans. Elevated IOP presents a major risk factor for glaucomatous field loss. The higher the level of IOP, the greater the likelihood of optic nerve damage and visual field loss.

Bimatoprost Absorption

Systemically absorbed when administered to the eye.

Bimatoprost side effects and Toxicity

In oral (by gavage) mouse and rat studies, doses up to 100 mg/kg/day did not produce any toxicity. This dose expressed as mg/m2 is at least 70 times higher than the accidental dose of one bottle of bimatoprost for a 10 kg child.

Bimatoprost Patient Information

Bimatoprost Organisms Affected

Humans and other mammals